Sanofi SA has extended and revamped its existing discovery pact with Warp Drive Bio - a move that increases chances the French group will buy the Boston-based biotech if they successfully use its two computational platforms to find new oncology drugs and antibiotics based on natural products.
Privately-held Warp Drive Bio, which operates on the core principle that nature is the world's most powerful inventor of new drugs, exploits natural molecules and mechanisms to create novel therapies....
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?
